Skip to content

Regenxbio RGNX Unbilled Revenue

Discontinued — last reported Q4 '15

Unbilled Revenue at other companies

BlackSky Technology logo
BlackSky TechnologyBKSY
$24.17M-25.5%
ePlus logo
ePlusPLUS
$17.81M+29.3%
ROP
Roper Technologies, Inc.ROP
$142.7M+5.2%
Huron Consulting Group logo
Huron Consulting GroupHURN
$235.38M+30.2%
Everspin Technologies logo
Everspin TechnologiesMRAM
$230K
N-able logo
N-ableNABL
$14.25M+43.5%

Segments

By product

See full
Nippon Shinyaku Services$2.17M

Other financials

Income statement

See full
Revenue$6.4M-92.8%
Gross profit$14.9M+35.7%
Operating income-$83.4M-787%
Net income-$90.1M-1,580%
EPS (diluted)-$1.72-1,533%

Balance sheet

See full
Cash & equivalents$15.2M-88.3%
Total debt$71.1M-11.0%
Total equity$21.1M-92.3%
Total assets$341.9M-30.4%

Cash flow

See full
Operating cash flow-$76.2M-327%
CapEx$1.2M+20.6%
Free cash flow-$77.4M-337%

Valuation

See full
Market cap$529.38M+24.6%
Enterprise value$585.22M+56.3%
P/S+3.3×

Profitability

See full
Gross margin59.7%+1.0pp
Operating margin-292.3%-613pp
Net margin-330.2%-588pp
FCF margin-269.2%-364pp

Returns & leverage

See full
Return on equity-196.4%-288pp
Debt / equity3.4×+3.1×
Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:UnbilledReceivablesCurrent.

The official record: Regenxbio’s 10-K, filed March 3, 2016, on SEC EDGAR. View the filing →